Skip to content
akaturk Academic measurement
Sign in Sign up
2025 SJR Q1 JCR Q1 · 4,7 383 matched articles SCIE

Journal detail

Advances in Therapy

Country
United Kingdom · Western Europe
Type
journal
ISSN
  • 0741238X
  • 18658652
Scopus 1,418 SJR
Scopus Q1 SJR Q
WoS Q1 JCR Q
WoS 4,7 JIF
Scopus 99 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 1,418
  • Quartile Q1
  • H-Index 99
  • Cites/doc 4,52
  • Docs (3y) 992
  • Cites (3y) 4.454

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q1
  • JIF 4,7
  • 5Y JIF 4,6
  • JCI 0,89

WoS indexes

  • SCIE

Subject classification

Categories (SJR)

Areas

WoS categories

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q1 Q1 1,418 4,7 4,6 0,89 Q2 99
2024 Q1 Q1 1,236 4,1 4,2 0,84 Q2 89
2023 Q1 Q2 1,089 3,4 4 0,79 Q2 89
2022 Q1 Q2 1,076 3,8 4,2 0,74 Q2 89
2021 Q1 Q2 1,032 4,1 4,5 0,77 Q2 89
2020 Q1 Q2 1,097 3,8 4,3 0,93 Q2 89
2019 Q1 Q1 0,979 3,9 3,6 0,96 Q2 89
2018 — Q2 — 3,3 3,1 1,05 Q1 —
2017 Q1 Q2 1,075 3,1 3 0,94 Q2 89
2016 Q1 Q2 0,974 2,7 2,7 — — 89
2015 Q2 Q2 0,843 2,5 2,4 — — 89
2014 Q2 Q3 0,851 2,3 2,1 — — 89
2013 Q1 Q2 0,874 2,4 1,9 — — 89
2012 Q2 Q3 0,699 2,1 1,7 — — 89
2011 Q2 Q3 0,692 2,1 1,5 — — 89
2010 Q2 Q3 0,46 1,7 1,3 — — 89
2009 — Q4 — 0,9 1 — — —
2008 — Q4 — 1 1 — — —
2007 — Q4 — 0,7 0,8 — — —
2006 — Q4 — 0,7 — — — —
2005 — Q4 — 0,7 — — — —
2004 — Q4 — 0,8 — — — —
2003 — Q3 — 1 — — — —
2002 — Q3 — 0,8 — — — —
2001 — Q4 — 0,5 — — — —
2000 — Q3 — 0,9 — — — —
1999 — Q4 — 0,4 — — — —
1998 — Q4 — 0,4 — — — —
1997 — Q4 — 0,4 — — — —

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q2 56/191
2025 PHARMACOLOGY & PHARMACY SCIE Q1 Q2 78/356
2024 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q2 60/195
2024 PHARMACOLOGY & PHARMACY SCIE Q1 Q2 79/352
2023 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q2 76/189
2023 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 105/354
2022 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q2 73/136
2022 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 105/278
2021 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q2 77/139
2021 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 111/279
2020 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 Q2 75/140
2020 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 119/276
2019 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q2 54/139
2019 PHARMACOLOGY & PHARMACY SCIE Q1 Q2 65/271
2018 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q2 59/136
2018 PHARMACOLOGY & PHARMACY SCIE Q2 Q1 86/267
2017 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 Q2 58/133
2017 PHARMACOLOGY & PHARMACY SCIE Q2 Q2 91/261
2016 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 58/128
2016 PHARMACOLOGY & PHARMACY SCIE Q2 — 114/257
2015 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 59/124
2015 PHARMACOLOGY & PHARMACY SCIE Q2 — 111/255
2014 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 66/123
2014 PHARMACOLOGY & PHARMACY SCIE Q3 — 132/255
2013 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 — 56/124
2013 PHARMACOLOGY & PHARMACY SCIE Q2 — 117/256
2012 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 67/121
2012 PHARMACOLOGY & PHARMACY SCIE Q3 — 137/261
2011 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 59/112
2011 PHARMACOLOGY & PHARMACY SCIE Q3 — 134/261
2010 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 62/106
2010 PHARMACOLOGY & PHARMACY SCIE Q3 — 164/252
2009 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 79/93
2009 PHARMACOLOGY & PHARMACY SCIE Q4 — 194/237
2008 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 70/83
2008 PHARMACOLOGY & PHARMACY SCIE Q4 — 183/219
2007 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 70/81
2007 PHARMACOLOGY & PHARMACY SCIE Q4 — 182/205
2006 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 63/76
2006 PHARMACOLOGY & PHARMACY SCIE Q4 — 177/199
2005 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 62/72
2005 PHARMACOLOGY & PHARMACY SCIE Q4 — 172/193
2004 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 55/71
2004 PHARMACOLOGY & PHARMACY SCIE Q4 — 152/187
2003 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 49/72
2003 PHARMACOLOGY & PHARMACY SCIE Q3 — 134/185
2002 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 56/74
2002 PHARMACOLOGY & PHARMACY SCIE Q3 — 139/188
2001 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 65/75
2001 PHARMACOLOGY & PHARMACY SCIE Q4 — 170/186
2000 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q3 — 49/74
2000 PHARMACOLOGY & PHARMACY SCIE Q3 — 124/181
1999 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 66/76
1999 PHARMACOLOGY & PHARMACY SCIE Q4 — 158/175
1998 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 57/72
1998 PHARMACOLOGY & PHARMACY SCIE Q4 — 154/178
1997 MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q4 — 51/61
1997 PHARMACOLOGY & PHARMACY SCIE Q4 — 144/157